Franco P A, Ferri S, Di Mummo O
Curr Med Res Opin. 1977;5(1):74-6. doi: 10.1185/03007997709108980.
Preliminary results in 12 patients with rheumatoid arthritis are presented from an on-going double-blind, between patient comparison of flurbiprofen and phenylbutazone. Patients received either 300 mg flurbiprofen daily or 400 mg phenylbutazone daily over a 2-week treatment period. Two patients treated with phenylbutazone developed a rash, and treatment was discontinued in 1 of them after Day 2.
本文展示了12例类风湿性关节炎患者正在进行的氟比洛芬与保泰松双盲、患者间对照试验的初步结果。在为期2周的治疗期间,患者每日服用300毫克氟比洛芬或400毫克保泰松。两名接受保泰松治疗的患者出现皮疹,其中1例在第2天后停止治疗。